PRESS RELEASE published on 03/14/2025 at 07:30, 1 year 5 months ago Inside Information / News release on accounts, results Sensorion reports full-year 2024 results and provides corporate update with significant milestones achieved in gene therapy clinical trials and financial highlights. Company well positioned for growth in 2025 Clinical Trials Financial Highlights Gene Therapy Full-year Results Sensorion
BRIEF published on 03/07/2025 at 07:35, 1 year 5 months ago Sensorion Completes Recruitment for NOTOXIS Trial of SENS-401 Clinical Trial Sensorion SENS-401 Cisplatin Ototoxicity
PRESS RELEASE published on 03/07/2025 at 07:30, 1 year 5 months ago Inside Information / Other news releases Sensorion completes patient enrollment in NOTOXIS Phase 2a Clinical Trial of SENS-401 for Cisplatin-Induced Ototoxicity prevention, targeting a significant unmet medical need Clinical Trial Sensorion SENS-401 NOTOXIS Cisplatin-Induced Ototoxicity
BRIEF published on 02/21/2025 at 07:35, 1 year 5 months ago Sensorion's SENS-501 Clinical Trial Progresses with Positive DMC Recommendation Gene Therapy Clinical Trial Sensorion Hearing Loss SENS-501
PRESS RELEASE published on 02/21/2025 at 07:30, 1 year 5 months ago Inside Information / Other news releases Sensorion receives positive recommendation from Data Monitoring Committee for Audiogene Phase 1/2 clinical trial of SENS-501 gene therapy program to treat congenital deafness linked to OTOF gene mutations Gene Therapy Sensorion Audiogene Deafness Data Monitoring Committee
BRIEF published on 02/20/2025 at 07:35, 1 year 5 months ago Sensorion to Participate in March Investor Conferences Biotechnology Investor Conferences Sensorion Hearing Loss Therapies March 2025
PRESS RELEASE published on 02/20/2025 at 07:30, 1 year 5 months ago Inside Information / Other news releases Sensorion announces participation in investor conferences in March. CEO and CFO will attend Cowen and Leerink events to present company updates and meet investors Biotechnology CFO Investor Conferences CEO Sensorion
BRIEF published on 02/18/2025 at 07:35, 1 year 6 months ago Sensorion announces its participation in congresses in March 2025 Biotechnology Sensorion Hearing Therapies Medical Innovations Congress 2025
PRESS RELEASE published on 02/18/2025 at 07:30, 1 year 6 months ago Inside Information / Other news releases Sensorion announces participation in upcoming congresses in March to present on innovative biologics and manufacturing challenges for hearing loss disorders Sensorion Hearing Loss Biologics Congresses Manufacturing Challenges
BRIEF published on 02/12/2025 at 11:35, 1 year 6 months ago Sensorion to Participate in ARO 48th Annual Midwinter Meeting Sensorion Hearing Loss ARO Meeting GJB2-GT Therapy Biotech Conference
Published on 08/19/2026 at 07:00, 48 minutes ago Caldwell Strengthens Life Sciences and Healthcare Practice with Addition of Olga Kozlova in Dubai
Published on 08/19/2026 at 04:00, 3 hours 48 minutes ago Momenta, XHEART, and QNX Build an Autonomous Driving Platform Certified to Global Safety Standards
Published on 08/18/2026 at 23:10, 8 hours 38 minutes ago Secure Blockchain Signs Agreement to Sell Delivery Trust(R) Business
Published on 08/18/2026 at 19:45, 12 hours 3 minutes ago ECC Ventures 5 Corp. Enters Into Business Combination Agreement with Bayrock Resources for Qualifying Transaction
Published on 08/18/2026 at 18:30, 13 hours 18 minutes ago Sterling Metals Announces Approval of Arrangement by QcX Gold Shareholders
Published on 08/19/2026 at 07:30, 18 minutes ago Exasol AG confirms preliminary figures for the first half of 2026 and publishes Half-Year Report
Published on 08/19/2026 at 07:30, 18 minutes ago Flughafen Wien AG in the first half of 2026: Earnings improvement of 7.0% thanks to international growth and cost discipline despite difficult market conditions and stagnating revenue (+0.9%)
Published on 08/19/2026 at 07:30, 18 minutes ago Steyr Motors confirms long-term growth strategy with strong order backlog and attractive project pipeline
Published on 08/19/2026 at 07:30, 18 minutes ago Deutsche Rohstoff AG: EBITDA rises to EUR 205 million in the first half of 2026
Published on 08/18/2026 at 11:15, 20 hours 33 minutes ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 1 day 12 hours ago Aéroports de Paris S.A - July 2026 traffic figures
Published on 08/17/2026 at 08:33, 1 day 23 hours ago Covivio - Information on Treasury shares transactions between August 10th, 2026 and August 11th, 2026
Published on 08/17/2026 at 07:30, 2 days ago Disclosure of transactions in own shares from August 10 to August 14, 2026
